HCG (Human Chorionic Gonadotropin): The Research Guide
Human chorionic gonadotropin is one of the most closely mapped glycoprotein hormones in the literature, studied for the way it engages the luteinising hormone receptor across the hormonal axis. This guide covers what it is, how it works, and what it is investigated for. Supplied strictly for laboratory and research use only, not for human consumption.
What is HCG?
HCG, or human chorionic gonadotropin, is a glycoprotein hormone that sits at the centre of a great deal of hormonal-axis research. It belongs to the same family as luteinising hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH), and it is one of the most thoroughly characterised signalling molecules in reproductive endocrinology. In humans it is produced by the syncytiotrophoblast of the placenta, where it plays a well-documented signalling role in early pregnancy, which is why it has been studied continuously for the better part of a century.
Structurally, HCG is built from two subunits held together non-covalently. The alpha subunit is shared with LH, FSH and TSH, while the beta subunit is largely unique to HCG and is what gives the molecule its biological specificity. This is why laboratory assays for pregnancy and for certain research markers target beta-hCG rather than the shared alpha chain. The intact molecule weighs in at roughly 36 to 37 kilodaltons and is heavily glycosylated, with carbohydrate making up close to a third of its mass.
Every statement below describes what human chorionic gonadotropin is studied for in published preclinical and clinical research, or how the compound is handled in a laboratory. Nothing here is guidance for use in a person. HCG is supplied by NovaPeptides for research use only.
Mechanism and receptor targets
What makes HCG so useful as a research tool is the precision of its mechanism. It binds the LH/CG receptor, written LHCGR, which is the very same receptor that luteinising hormone uses. Because it activates that receptor so faithfully, researchers describe HCG as an LH mimetic, and it is frequently used in the literature as a stable, long-acting stand-in for LH in experimental systems.
The LHCGR is a class A G protein-coupled receptor. When HCG binds, the receptor couples to the Gs protein and drives up intracellular cyclic AMP, which activates protein kinase A (PKA). In Leydig cells of the testis, this cascade upregulates the steroidogenic acute regulatory protein (StAR) and the downstream steroidogenic enzymes, which together govern the conversion of cholesterol into testosterone. In the ovary, the same receptor on theca, granulosa and corpus luteum cells is studied for its role in progesterone signalling.
The receptor pathway at a glance
- LHCGR binding: HCG engages the luteinising hormone/choriogonadotropin receptor, a GPCR shared with LH
- cAMP and PKA: receptor activation raises cyclic AMP and switches on protein kinase A signalling
- Steroidogenesis: StAR protein and steroidogenic enzymes are upregulated, the pathway studied in testosterone and progesterone research
- Cell targets: Leydig cells in the testis and theca, granulosa and corpus luteum cells in the ovary
One of the most studied features of HCG is its durability in circulation. Because it is so heavily glycosylated, with sialic acid residues that resist rapid clearance, its circulating half-life is measured in the order of a day or more, whereas luteinising hormone is cleared within roughly twenty to thirty minutes. That contrast, a near-identical receptor action paired with a far longer signalling window, is a large part of why HCG features so often in hormonal-axis experiments.
What HCG is studied for
Because it activates the LH pathway so cleanly, HCG appears across a broad research footprint. The dominant theme is the hypothalamic-pituitary-gonadal (HPG) axis, the feedback loop that governs endogenous sex-hormone production, and how it responds when an LH-like signal is applied directly at the gonadal level.
Research areas where HCG features
- Endogenous testosterone research: Leydig cell steroidogenesis and the cAMP/StAR pathway that produces testosterone
- HPG axis signalling: how the gonadal end of the axis responds to a direct LH-receptor agonist
- Spermatogenesis and testicular function: models of hypogonadotropic states where gonadotropin signalling is investigated
- Ovarian and luteal research: corpus luteum function and progesterone signalling in reproductive models
- The HCG stimulation test: a long-standing research and diagnostic protocol used to assess Leydig cell responsiveness
- Structure-function studies: how the beta subunit and the glycosylation pattern shape receptor binding and signalling
In reproductive-signalling research specifically, HCG is valued because its long half-life produces a sustained, measurable receptor stimulus. That lets investigators separate the gonadal response from the pulsatile release patterns of endogenous LH, which is difficult to isolate in intact systems. The beta-hCG subunit is also a workhorse of laboratory measurement, serving as the target analyte in pregnancy assays and as a marker studied in certain oncology research contexts.
Each of the areas above describes a field of investigation. None of it is a claim that HCG treats, cures or improves any condition in a person. The value of the compound in this setting is as a precise experimental probe of a well-mapped receptor pathway.
The research landscape
HCG has an unusually deep and long-running body of literature behind it, which is one reason researchers regard it as a well-understood reference compound rather than a novel unknown. The molecule was first isolated in the early twentieth century, and its receptor, subunit structure and signalling cascade have since been resolved in fine detail, including crystallographic and cryo-electron microscopy work on the hormone bound to its receptor.
Historically, HCG used in research and clinical settings was purified from the urine of pregnant women, which remains a recognised source. Recombinant HCG, produced in cultured cell lines and known generically as choriogonadotropin alfa, was later developed to give a more defined and reproducible preparation. Comparative work between urinary-derived and recombinant material is itself an area of study, particularly around glycosylation differences and their effect on receptor activity and half-life.
Why HCG is a reference-grade research target
- A fully characterised receptor: the LHCGR structure and activation mechanism are well described in the literature
- A defined subunit architecture: the shared alpha and specific beta subunits are mapped in detail
- Decades of comparative data: urinary-derived and recombinant preparations have both been extensively studied
- A clear LH comparator: HCG is routinely benchmarked against luteinising hormone in axis research
Human chorionic gonadotropin is described in the literature as a luteinising hormone analogue that binds the shared LH/CG receptor, distinguished by its extensive glycosylation and prolonged circulating half-life.
How HCG is handled in a lab context
HCG is supplied as a lyophilised, or freeze-dried, powder. As a glycoprotein it is more delicate than the small linear peptides that make up much of the research market, so laboratory handling notes tend to emphasise gentle reconstitution and careful cold-chain storage. The notes below describe general laboratory practice for the compound and are not instructions for use in a person.
General laboratory handling notes
- Storage of the lyophilised powder: kept cold, dry and away from light until it is prepared
- Reconstitution: dissolved in an appropriate diluent such as bacteriostatic water, added gently down the vial wall to avoid denaturing the glycoprotein
- Post-reconstitution: the solution is typically refrigerated, protected from light and used within the working window recorded by the laboratory
- Aliquoting: dividing into single-experiment aliquots is common practice to avoid repeated freeze-thaw cycles that can degrade a glycoprotein
For the underlying reconstitution arithmetic that laboratories rely on, where concentration equals the quantity of powder divided by the volume of diluent added, our reconstitution and storage references cover the general method used across research peptides. None of that material constitutes a protocol for administration to a person.
Sourcing and verification
With a glycoprotein like HCG, identity and purity matter even more than they do for a simple peptide, because glycosylation and subunit integrity are part of what defines the molecule. That is why every batch NovaPeptides supplies is independently tested and carries a verified Novagen Certificate of Analysis. The certificate documents the identity and purity of the specific batch, and it can be opened on the laboratory's own register rather than being taken on trust from a product page.
What a Certificate of Analysis confirms
- Identity: confirmation that the material in the vial is the compound stated on the label
- Purity: the measured purity of that specific batch, reported as a percentage
- Independence: testing carried out by Novagen, a separate analytical laboratory, not self-reported
- Traceability: a batch that can be checked against the lab's own public verification register
A genuine certificate is one you can open on the issuing laboratory's register and match to the batch in front of you. NovaPeptides links each batch to its Novagen certificate so the identity and purity behind the research are never in doubt.
Why researchers choose NovaPeptides
NovaPeptides is an Australian owned supplier based on the Gold Coast in Queensland, and we have supplied research peptides to Australian researchers for over three years. That track record matters in a category where consistency, honest labelling and verifiable testing are the whole point. We do not ask anyone to take our word for what is in a vial, because every batch is backed by a Novagen Certificate of Analysis you can check yourself.
What comes with HCG from NovaPeptides
- Verified Novagen COA: independent identity and purity testing on the exact batch supplied
- Single Vial or Full Kit: the compound on its own, or a kit that adds a reusable dosing pen, bacteriostatic water, a mixing syringe, needle tips and a travel case for laboratory handling
- Australian owned and Gold Coast based: a local supplier with over three years serving Australian researchers
- Tracked shipping Australia wide: standard and express options, with free express shipping once an order passes the qualifying threshold
The Full Kit exists because a glycoprotein arrives lyophilised and needs to be reconstituted before it can be studied. Bundling the handling equipment with the compound means a research batch arrives ready to prepare in one box, all traceable back to the same certificate.
Research use status in Australia
Here is the plain position. HCG is not approved by the Therapeutic Goods Administration (TGA) for supply as a consumer product. In Australia human chorionic gonadotropin is a prescription-only medicine, and the material NovaPeptides supplies is provided strictly for laboratory and research use only. It is not for human consumption, and nothing on this page should be read as encouragement to use it in a person.
What research use only means here
- Not TGA approved for human use: HCG supplied by NovaPeptides is not an approved therapeutic good
- Laboratory and research use only: the compound is intended for in-vitro and research applications
- No personal protocols: this guide describes mechanism and research areas, never dosing for a person
- Honest framing: every reference to effects describes findings in research models, not outcomes promised to an individual
HCG from NovaPeptides is supplied for laboratory and research use only. It is not TGA approved for human use and is not for human consumption. This guide is educational reference material about the compound and its research literature.
Frequently asked questions
What is HCG?+
HCG, or human chorionic gonadotropin, is a glycoprotein hormone made up of a shared alpha subunit and a specific beta subunit. In humans it is produced by the placenta, and in research it is studied as an agonist of the LH/CG receptor. NovaPeptides supplies it for research use only, not for human consumption.
How does HCG work at the receptor level?+
HCG binds the LH/CG receptor (LHCGR), the same G protein-coupled receptor that luteinising hormone uses. Binding raises intracellular cyclic AMP and activates protein kinase A, which in Leydig cells drives the steroidogenic pathway that produces testosterone. Because its action mirrors LH, HCG is described in the literature as an LH mimetic.
What is HCG studied for in research?+
It features across hormonal-axis and reproductive-signalling research, including Leydig cell steroidogenesis, endogenous testosterone production, the hypothalamic-pituitary-gonadal axis, spermatogenesis in hypogonadotropic models, and ovarian corpus luteum and progesterone signalling. These are fields of investigation, not outcomes promised to a person.
Why does HCG have a longer half-life than LH?+
HCG is heavily glycosylated, with sialic acid residues that slow its clearance from circulation. Research reports its half-life in the order of a day or more, compared with roughly twenty to thirty minutes for luteinising hormone. That longer, sustained receptor stimulus is one reason it is used as a research stand-in for LH.
What is the difference between beta-hCG and intact HCG?+
Intact HCG is the whole two-subunit molecule. The beta subunit is the part largely unique to HCG, which is why laboratory assays for pregnancy and certain research markers measure beta-hCG rather than the alpha subunit that is shared with LH, FSH and TSH.
Is HCG legal to buy in Australia?+
HCG is a prescription-only medicine in Australia and is not TGA approved for supply as a consumer product. NovaPeptides supplies it strictly for laboratory and research use only, not for human consumption. This guide does not provide guidance for use in a person.
What is recombinant HCG?+
Recombinant HCG, known generically as choriogonadotropin alfa, is produced in cultured cell lines to give a defined, reproducible preparation. Historically HCG was purified from the urine of pregnant women, and comparative research between the two sources looks at glycosylation differences and their effect on receptor activity.
How is HCG handled in a laboratory?+
It is supplied lyophilised and, as a glycoprotein, is treated gently. General laboratory practice is to reconstitute it in an appropriate diluent added slowly down the vial wall, keep the solution cold and out of light, and aliquot it to avoid repeated freeze-thaw cycles. These are handling notes for the compound, not instructions for use in a person.
Does every batch come with a Certificate of Analysis?+
Yes. Every batch NovaPeptides supplies carries a verified Novagen Certificate of Analysis that documents the identity and purity of that specific batch. You can open the certificate on the laboratory's own register and match it to the vial, rather than relying on a self-reported figure.
Why buy HCG from NovaPeptides?+
NovaPeptides is Australian owned and based on the Gold Coast, and has supplied research peptides to Australian researchers for over three years. Every batch is backed by an independent Novagen COA, and HCG is available as a Single Vial or as a Full Kit with the handling equipment included. It is supplied for research use only.
Can HCG be used for human consumption?+
No. Everything NovaPeptides supplies is provided strictly for laboratory and research use only. HCG is not TGA approved for human use and is not for human consumption. This guide is educational reference material about the compound and its research literature.
Questions? Talk to us.
Message us on WhatsApp and we will walk you through the kits, the COAs, reconstitution and the dose tool.
Chat with us on WhatsApp